Artificial Breeding Research Centre, LPM Division, ICAR-National Dairy Research Institute, Karnal, Haryana, India.
Animal Reproduction, Gynaecology and Obstetrics, LPM Division, ICAR-National Dairy Research Institute, Karnal, Haryana, India.
Cryobiology. 2021 Aug;101:125-134. doi: 10.1016/j.cryobiol.2021.04.007. Epub 2021 Apr 30.
The present study compared the effect of mitochondria-targeted (Mitoquinone, MitoQ) and untargeted cytosolic antioxidant (Resveratrol, RESV) supplementation on lipid peroxidation (LPO) and in-vitro sperm functions of cryopreserved buffalo bull semen. To optimize additive's concentration, sperm pellet obtained from twenty-four ejaculates was supplemented with different concentrations of MitoQ (20 nM, 100 nM, 200 nM); and RESV (10 μM, 25 μM, 50 μM) against control in the extender. The post-thaw sperm motility, livability, and membrane integrity were higher (P < 0.05) in 200 nM MitoQ and 50 μM RESV than other concentrations used. In another experiment, sperm pellet from thirty-two ejaculates was supplemented with 200 nM MitoQ and 50 μM RESV in the extender. Pre-freeze and post-thaw progressive motility and livability were higher (P < 0.05) in MitoQ (200 nM) than RESV (50 μM) treatment. MitoQ supplementation improved post-thaw membrane integrity (CFDA-PI) higher (P < 0.05) than RESV, however, hypo-osmotic swelling response observed no improvement with RESV treatment. Post-thaw LPO rate was lower (P < 0.05) and Bovine cervical mucus penetration was higher (P < 0.05) in MitoQ than RESV treatment. In post-thaw semen, MitoQ showed higher (P < 0.05) proportion of acrosome intact (FITC-PNA), live non-apoptotic (P < 0.01) sperm with a higher reduction (P < 0.05) in membrane scrambling. MitoQ improved (P < 0.01) proportion of sperm with high Mitochondrial Membrane Potential and low LPO (P < 0.01) than RESV treatment. In conclusion, improvement in post-thaw in-vitro sperm functions and cryo-tolerance was more evident in MitoQ than RESV supplemented buffalo bull semen. Our study provides a better strategy to mitigate oxidative stress by enhancing mitochondrial antioxidant system with targeted antioxidants than cytosolic antioxidant supplementation.
本研究比较了靶向线粒体(Mitoquinone,MitoQ)和非靶向胞质抗氧化剂(Resveratrol,RESV)对冷冻水牛公牛精液脂质过氧化(LPO)和体外精子功能的影响。为了优化添加剂的浓度,从 24 个精液样本中获得的精子沉淀分别用不同浓度的 MitoQ(20 nM、100 nM、200 nM)和 RESV(10 μM、25 μM、50 μM)在扩展剂中与对照组进行补充。与其他使用浓度相比,200 nM MitoQ 和 50 μM RESV 处理后的解冻后精子活力、存活率和膜完整性更高(P<0.05)。在另一个实验中,从 32 个精液样本中获得的精子沉淀在扩展剂中添加 200 nM MitoQ 和 50 μM RESV。预冷冻和解冻后,运动能力和存活率较高(P<0.05)MitoQ(200 nM)处理组高于 RESV(50 μM)处理组。与 RESV 处理相比,MitoQ 处理可提高解冻后膜完整性(CFDA-PI)(P<0.05),但 RESV 处理后低渗肿胀反应未见改善。解冻后 LPO 率较低(P<0.05),牛宫颈黏液穿透率较高(P<0.05)MitoQ 处理组高于 RESV 处理组。在解冻后的精液中,MitoQ 处理组显示出更高的(P<0.05)顶体完整(FITC-PNA)比例、活非凋亡(P<0.01)精子比例,并降低了(P<0.05)膜重排。与 RESV 处理相比,MitoQ 处理可提高(P<0.01)具有高线粒体膜电位和低 LPO(P<0.01)的精子比例。总之,与 RESV 处理相比,MitoQ 处理可明显改善解冻后体外精子功能和耐冷冻性。我们的研究提供了一种更好的策略,通过增强靶向抗氧化剂的线粒体抗氧化系统来减轻氧化应激,而不是通过胞质抗氧化剂补充。